These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1912391)

  • 21. Oxalate Balance in Peritoneal Dialysis Patients: A Potential Role of Dialysis-related Peritonitis.
    Stepanova N; Korol L; Lebid L; Snisar L; Savchenko S
    In Vivo; 2022; 36(2):925-933. PubMed ID: 35241551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxalate removal by differing dialysis techniques.
    Dell'Aquila R; Feriani M; Mascalzoni E; Bragantini L; Ronco C; La Greca G
    ASAIO J; 1992; 38(4):797-800. PubMed ID: 1450473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of vitamin C intake on plasma oxalate in patients on regular haemodialysis.
    Rolton HA; McConnell KM; Modi KS; Macdougall AI
    Nephrol Dial Transplant; 1991; 6(6):440-3. PubMed ID: 1876286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major factors modulating the serum oxalic acid level in hemodialysis patients.
    Ogawa Y; Machida N; Jahana M; Gakiya M; Chinen Y; Oda M; Morozumi M; Sugaya K
    Front Biosci; 2004 Sep; 9():2901-8. PubMed ID: 15353324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study of erythrocyte oxalate flux rate and urinary oxalate excretion in hyperoxaluric rats.
    Kaul P; Sidhu H; Sharma SK; Thind SK; Nath R
    Biochem Mol Biol Int; 1993 Sep; 31(1):83-93. PubMed ID: 8260949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxalic Acid as a uremic toxin.
    Mydlík M; Derzsiová K
    J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure.
    Hoppe B; Kemper MJ; Bökenkamp A; Portale AA; Cohn RA; Langman CB
    Kidney Int; 1999 Jul; 56(1):268-74. PubMed ID: 10411702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The oxalate level in ultrafiltrate fluid collected from a dialyzer is useful for estimating the plasma oxalate level in hemodialysis patients.
    Ogi M; Abe R; Nishitani T; Wakabayashi M; Wakabayashi T
    Clin Exp Nephrol; 2006 Jun; 10(2):118-23. PubMed ID: 16791397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma profiles and dialysis kinetics of oxalate in patients receiving hemodialysis.
    Marangella M; Petrarulo M; Mandolfo S; Vitale C; Cosseddu D; Linari F
    Nephron; 1992; 60(1):74-80. PubMed ID: 1738418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma oxalate in patients receiving continuous ambulatory peritoneal dialysis.
    Tomson CR; Channon SM; Parkinson IS; Owen JP; Ward MK; Simpson JM; Laker MF
    Nephrol Dial Transplant; 1988; 3(3):295-9. PubMed ID: 3140104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of acquired renal cysts in hemodialysis patients. The role of oxalate crystal deposition in renal tubules.
    Ono K; Yasukohchi A; Kikawa K
    ASAIO Trans; 1987; 33(3):245-9. PubMed ID: 3314920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correction of subclinical ascorbate deficiency in patients receiving dialysis: effects on plasma oxalate, serum cholesterol, and capillary fragility.
    Tomson CR; Channon SM; Parkinson IS; McArdle P; Qureshi M; Ward MK; Laker MF
    Clin Chim Acta; 1989 Apr; 180(3):255-64. PubMed ID: 2743578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum oxalate in chronic renal failure.
    Borland WW; Payton CD; Simpson K; Macdougall AI
    Nephron; 1987; 45(2):119-21. PubMed ID: 3561621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxalate quantification in hemodialysate to assess dialysis adequacy for primary hyperoxaluria.
    Tang X; Voskoboev NV; Wannarka SL; Olson JB; Milliner DS; Lieske JC
    Am J Nephrol; 2014; 39(5):376-82. PubMed ID: 24776840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ascorbate-induced hyperoxalaemia has no significant effect on lactate generation or erythrocyte 2,3,diphosphoglycerate in dialysis patients.
    Tomson CR; Channon SM; Ward MK; Laker MF
    Eur J Clin Invest; 1990 Aug; 20(4):411-5. PubMed ID: 2121500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recovery From Dialysis in Patients With Primary Hyperoxaluria Type 1 Treated With Pyridoxine: A Report of 3 Cases.
    Lorenz EC; Lieske JC; Seide BM; Olson JB; Mehta R; Milliner DS
    Am J Kidney Dis; 2021 May; 77(5):816-819. PubMed ID: 32891627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ascorbic acid aggravates secondary hyperoxalemia in patients on chronic hemodialysis.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Haubenstock A
    Ann Intern Med; 1984 Sep; 101(3):344-5. PubMed ID: 6465702
    [No Abstract]   [Full Text] [Related]  

  • 38. Modified enzyme-based colorimetric assay of urinary and plasma oxalate with improved sensitivity and no ascorbate interference: reference values and sample handling procedures.
    Wilson DM; Liedtke RR
    Clin Chem; 1991 Jul; 37(7):1229-35. PubMed ID: 1855295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxalosis Associated With High-Dose Vitamin C Ingestion in a Peritoneal Dialysis Patient.
    D'Costa MR; Winkler NS; Milliner DS; Norby SM; Hickson LJ; Lieske JC
    Am J Kidney Dis; 2019 Sep; 74(3):417-420. PubMed ID: 30910370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocardial calcinosis associated with hemodialysis.
    Zazgornik J; Balcke P; Biesenbach G; Kaiser W; Stockenhuber F
    Am J Cardiol; 1987 Aug; 60(4):421-2. PubMed ID: 3618514
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.